SPY423.67-0.64 -0.15%
DIA343.43-1.69 -0.49%
IXIC14,099.56+30.14 0.21%

Prelude Therapeutics Q1 EPS $(0.47)

Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.47) per share.

05/11/2021 07:57
Prelude Therapeutics (NASDAQ:PRLD) reported quarterly losses of $(0.47) per share.